Cns Pharmaceuticals Inc’s recent filing unveils that its Chief Executive Officer Climaco John M acquired Company’s shares for reported $50000.0 on Feb 01 ’24. In the deal valued at $0.30 per share,166,666 shares were bought. As a result of this transaction, Climaco John M now holds 215,676 shares worth roughly $47448.72.
Then, Downs Christopher bought 66,666 shares, generating $20,000 in total proceeds. Upon buying the shares at $0.30, the Chief Financial Officer now owns 103,438 shares.
Before that, Evans Carl Anthony bought 33,333 shares. Cns Pharmaceuticals Inc shares valued at $10,000 were divested by the Director at a price of $0.30 per share. As a result of the transaction, Evans Carl Anthony now holds 33,458 shares, worth roughly $7360.76.
Ladenburg Thalmann downgraded its Cns Pharmaceuticals Inc [CNSP] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating.
Price Performance Review of CNSP
On Monday, Cns Pharmaceuticals Inc [NASDAQ:CNSP] saw its stock fall -13.38% to $0.22. Over the last five days, the stock has lost -37.74%. Cns Pharmaceuticals Inc shares have fallen nearly -82.36% since the year began. Nevertheless, the stocks have fallen -74.13% over the past one year. While a 52-week high of $4.40 was reached on 01/02/24, a 52-week low of $0.23 was recorded on 04/08/24. SMA at 50 days reached $0.3210, while 200 days put it at $1.3539. A total of 0.79 million shares were traded, compared to the trading of 0.22 million shares in the previous session.
Levels Of Support And Resistance For CNSP Stock
The 24-hour chart illustrates a support level at 0.2028, which if violated will result in even more drops to 0.1817. On the upside, there is a resistance level at 0.2623. A further resistance level may holdings at 0.3007. The Relative Strength Index (RSI) on the 14-day chart is 26.26, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0772, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.18%. Stochastics %K at 2.22% indicates the stock is a buying.
How much short interest is there in Cns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Cns Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 1240.0 shares to a total of 0.1 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.1 million shares. There was a rise of 1.19%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.24% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.31.
